Treatment of intravascular coagulation and fibrinolysis (ICF) syndromes.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000783:Aneurysm / Q000150:complications; D002648:Child; D002908:Chronic Disease; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D004619:Embolism, Amniotic Fluid / Q000150:complications; D005260:Female; D005313:Fetal Death / Q000150:complications; D005342:Fibrinolysis; D006391:Hemangioma / Q000097:blood / Q000150:complications; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007083:Iliac Artery; D007263:Infusions, Parenteral; D008175:Lung Neoplasms / Q000150:complications; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000150:complications; D008875:Middle Aged; D011247:Pregnancy; D018805:Sepsis / Q000150:complications; D013290:Streptococcal Infections / Q000150:complications; D013577:Syndrome; D013924:Thrombophlebitis / Q000188:drug therapy; D013933:Thumb; D014859:Warfarin / Q000627:therapeutic use
D014859:Warfarin; D006493:Heparin